Phase I/ II Trial Combining PD-1 Inhibition and Neoadjuvant Proton or Photon Radiation Therapy in Recurrent Head and Neck Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Head and Neck Cancer · Recurrent Head and Neck Squamous Cell Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • University of Cincinnati Medical Center, Cincinnati, Ohio, United States

    Contact: Study coordinator (UCCC CTO) · cancer@uchealth.com · 513-584-7698
    Contact: Principal Investigator (Jordan Kharofa, MD)